PTGFRN and cancer: Prostaglandin F2 receptor negative (PTGFRN) regulator is overexpressed in glioblastoma multiforme and associated with poor survival, downregulates its expression of radiosensitized cancer cells, and effectively slows down the rate of cell proliferation and tumor growth [31].